Hence, given the importance of VAV2 in head-and-neck cancer, we used human oral squamous cell carcinoma cell line HSC3 to fluorescently label endogenous VAV2 and its major substrate, Rac1, by CRISPR/Cas9 gene-editing. This evidence concerns the gene VAV2 and head and neck cancer.